Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson's disease, new research shows.

Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson's, and it was suggested that a class of rheumatoid arthritis drugs called disease-modifying antirheumatic drugs (DMARDs) may play a role in that reduced risk.

To learn mor...

Red wine may be a guilty pleasure, but new research shows it might also be a powerful weapon against the ravages of Parkinson's disease.

Why? The antioxidants in red wine, and fruit such as berries for that matter, might slow progression of the movement disorder, a new study suggests.

According to researchers, people with Parkinson's who eat three or more servings per week of f...

A few hours of exercise a week may help slow Parkinson's disease, even if it's just moderate activity such as walking or gardening, a new study suggests.

The key is to be consistent, the researchers found.

"Although medications can provide people with Parkinson's some symptom relief, they haven't been shown to slow the progression of the disease," said study author Dr. Kazuto Tsukit...

A defect in the blood-brain barrier may play a role in Parkinson's disease, a groundbreaking research study suggests.

The blood-brain barrier acts as a filter to keep out toxins while still allowing the passage of nutrients to nourish the brain. This study found that in some people with Parkinson's, the b...

Physiotherapist David Putrino was working on a vibrating glove to help deaf people experience live music when a friend mentioned that the same technology might stop tremors in people with Parkinson's disease.

Putrino, director of rehabilitation innovation for Mount Sinai Health System in New York City, was intrigued. The friend's father had Parkinson's, so they placed the new device on hi...

Guidelines for treating movement problems in people in the early stages of Parkinson's disease have been updated.

The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson's is a movement disorder that occurs when nerve cells in the brain fail to produce enough dopam...

An experimental gene therapy to boost the effectiveness of the Parkinson's drug levodopa yielded promising results in mice, researchers report.

As the loss of dopamine-releasing neurons advances in late-stage Parkinson's, levodopa is less able to ease movement problems caused by the disease, which is a progressive disorder of the nervous system.

But a Northwestern University team fo...

The number of Americans who are dying from Parkinson's disease has jumped by 63% in the past two decades, new research shows.

The fresh analysis also revealed that men face double the risk of dying from the progressive and incurable disease than women. A notably higher death rate was also seen among white people, as compared with peers of other racial/ethnic backgrounds.

"The messa...

FRIDAY, Sept. 17, 2021 (HealthDay News) -- Researchers hoped to show that the natural antioxidant urate could delay Parkinson's disease progression, but a study completed at Massachusetts General Hospital dashed those expectations.

The trial enrolled nearly 300 individuals recently diagnosed with early Parkinson's disease, which affects the body's motor system. Symptoms such as tremors,...

Movement can be very difficult for people with Parkinson's disease, as shaking and stiffness play havoc with balance, coordination and gait.

There are many different tricks Parkinson's patients can use to improve their walking and avoid injury from a bad tumble -- but a new study reveals that people often have to figure them out on their own, with no help from either a doctor or physical ...

A drug that eases hallucinations in people with Parkinson's disease may be able to do the same for those with dementia, a new clinical trial finds.

The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusions related to Parkinson's.

The new study, published July 22 in the New England Journal of Medicine, ...

The brains of people who died from COVID-19 were remarkably similar to the brains of people who die from neurodegenerative diseases such as Alzheimer's and Parkinson's, showing inflammation and disrupted circuitry, researchers report.

"The brains of patients who died from severe COVID-19 showed profound molecular markers of inflammation, even though those patients didn't have any reporte...

Parkinson's disease patients can get symptom relief with deep brain stimulation (DBS) therapy that lasts over the long term, a new study shows.

Over 15 years, patients who received DBS, which requires surgical implantation, had significant improvement in motor symptoms and less need for medication, researchers found.

"Our study, for the first time, supports the efficacy of deep brai...

Parkinson's disease is widely seen as a movement disorder, but it can cause an array of symptoms, including hallucinations. Now a new study has shed light on what is happening in the brain during those disturbances.

The study focused on Parkinson's patients who have so-called presence hallucinations -- a false feeling that another person is nearby.

Researchers found that they were a...